Latest News From Pharmachem

    May 2012

  • Pfizer reports first-quarter 2012 results

    Pfizer reports first-quarter 2012 results

    01 May, 2012

    Pfizer Inc. (NYSE: PFE) today reported financial results for first-quarter 2012. First-quarter 2012 revenues were $15.4 billion, a decrease of 7% compared with $16.5 billion in the year-ago quarter, which reflects an operational decline of $1.0 billion, or 6%, and the unfavorable impact of foreign exchange of $57 million, or less than 1%.

    Continue Reading »

  • Bristol-Myers Squibb and Tsinghua University Enter Strategic Partnership

    15 May, 2012

    Bristol-Myers Squibb Company (NYSE:BMY) and Tsinghua University of Beijing, China, today announced the formation of a multi-year strategic partnership. Under the agreement, Bristol-Myers Squibb will fund research efforts at Tsinghua University's School of Life Sciences to identify and validate novel targets in oncology and immunoscience.

    Continue Reading »